From October 1, 2023 to December 31, 2023, the company has repurchased 11,511,800 shares, representing 0.6% for CNY 53.54 million. With this, the company has completed the repurchase of 27,531,540 shares, representing 1.42% for CNY 127.48 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 CNY | +1.05% | +4.34% | -13.29% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.29% | 1.01B | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.